Institutional Ownership Prime Medicine, Inc. (PRME)
This table provides information about the institutional ownership of Prime Medicine, Inc. (PRME). We have compiled data on the 123 institutions that hold shares in the stock, with a total of 64.7 Million shares, which have been reported (via 13F filing form) to have a value of $192 Million.
Holding | Report Date | shares Held | Holding Value (Reported) | Last Trade | Trade History |
---|---|---|---|---|---|
Westwood Holdings Group Inc
Dallas, TX |
Nov 14, 2024 Q3 2024 |
449,476
shares
|
$1.44 Million
0.01% of portfolio
|
Q3 2024
Added 25.35%
|
|
Nuveen Asset Management, LLC
Chicago, IL |
Nov 14, 2024 Q3 2024 |
392,443
shares
|
$1.26 Million
0.0% of portfolio
|
Q2 2024
Added 160.98%
|
|
Casdin Capital, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
367,175
shares
|
$1.17 Million
0.11% of portfolio
|
Q2 2023
Reduced 50.0%
|
|
Bollard Group LLC
Boston, MA |
Nov 13, 2024 Q3 2024 |
361,136
shares
|
$1.16 Million
0.04% of portfolio
|
Q4 2023
New holding
|
|
Two Sigma Investments, LP
New York, NY |
Nov 14, 2024 Q3 2024 |
318,573
shares
|
$1.02 Million
0.0% of portfolio
|
Q3 2024
Reduced 53.25%
|
|
Morgan Stanley
New York, NY |
Nov 14, 2024 Q3 2024 |
300,391
shares
|
$961,251
0.0% of portfolio
|
Q3 2024
Added 63.29%
|
|
Trexquant Investment LP
Stamford, CT |
Nov 12, 2024 Q3 2024 |
242,160
shares
|
$774,912
0.01% of portfolio
|
Q3 2024
Added 6.11%
|
|
Goldman Sachs Group Inc
New York, NY |
Nov 14, 2024 Q3 2024 |
220,144
shares
|
$704,460
0.0% of portfolio
|
Q3 2024
Added 177.37%
|
|
Wells Fargo & Company
San Francisco, CA |
Nov 13, 2024 Q3 2024 |
171,468
shares
|
$548,697
0.0% of portfolio
|
Q3 2024
Added 742.26%
|
|
D. E. Shaw & Co., Inc.
New York, NY |
Nov 14, 2024 Q3 2024 |
139,451
shares
|
$446,243
0.0% of portfolio
|
Q3 2024
Added 206.92%
|
|
Fil LTD
Hamilton, D0 |
Nov 13, 2024 Q3 2024 |
129,861
shares
|
$415,555
0.0% of portfolio
|
Q3 2024
Reduced 6.09%
|
|
Squarepoint Ops LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
124,369
shares
|
$397,980
0.0% of portfolio
|
Q3 2024
Added 95.98%
|
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
Nov 14, 2024 Q3 2024 |
119,900
shares
|
$383,680
0.0% of portfolio
|
Q3 2024
Reduced 32.07%
|
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
Nov 14, 2024 Q3 2024 |
115,054
shares
|
$368,172
0.0% of portfolio
|
Q3 2024
Added 8.65%
|
|
Deutsche Bank Ag\
Frankfurt Am Main, 2M |
Nov 13, 2024 Q3 2024 |
114,907
shares
|
$367,702
0.0% of portfolio
|
Q3 2024
Reduced 75.07%
|
|
Walleye Capital LLC
Plymouth, MN |
Nov 14, 2024 Q3 2024 |
108,374
shares
|
$346,796
0.0% of portfolio
|
Q3 2024
New holding
|
|
Gsa Capital Partners LLP
London, X0 |
Nov 05, 2024 Q3 2024 |
99,060
shares
|
$316,992
0.03% of portfolio
|
Q3 2024
New holding
|
|
Vestmark Advisory Solutions, Inc.
|
Nov 14, 2024 Q3 2024 |
90,036
shares
|
$288,115
0.01% of portfolio
|
Q3 2024
Reduced 13.02%
|
|
Barclays PLC
London, X0 |
Nov 19, 2024 Q3 2024 |
84,697
shares
|
$271,030
0.0% of portfolio
|
Q3 2024
Added 343.35%
|
|
Chelsea Counsel CO
|
Nov 21, 2024 Q3 2024 |
78,690
shares
|
$251,808
0.15% of portfolio
|
Q3 2024
Added 1.29%
|
|
Sphera Funds Management Ltd.
Tel Aviv, L3 |
Nov 14, 2024 Q3 2024 |
76,456
shares
|
$244,659
0.05% of portfolio
|
Q3 2024
Reduced 40.0%
|
|
Alliancebernstein L.P.
New York, NY |
Nov 14, 2024 Q3 2024 |
76,000
shares
|
$243,200
0.0% of portfolio
|
Q3 2024
Added 8.28%
|
|
Rhumbline Advisers
Boston, MA |
Nov 12, 2024 Q3 2024 |
70,047
shares
|
$224,150
0.0% of portfolio
|
Q3 2024
Reduced 0.09%
|
|
Jane Street Group, LLC
New York, NY |
Nov 14, 2024 Q3 2024 |
57,548
shares
|
$184,153
0.0% of portfolio
|
Q3 2024
Reduced 65.83%
|
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
Nov 14, 2024 Q3 2024 |
50,995
shares
|
$163,184
0.0% of portfolio
|
Q3 2024
Added 300.72%
|